MMED Analyst Ratings
MiniMed Group, Inc. (MMED) operates in the Healthcare sector, specifically the Medical - Equipment & Services industry, with a market capitalization near $5.17B, listed on NASDAQ, employing roughly 8,000 people, carrying a beta of -3.71 to the broader market. MiniMed Group, Inc. Led by Que Thanh Dallara, public since 2026-03-05.
Analyst Ratings
In the October 2026 monthly count, 15 analysts rated MMED: 1 Strong Buy, 10 Buy, 3 Hold, 0 Sell and 1 Strong Sell.
Price Targets
- Average Target
- $25.73
- Median Target
- $28.00
- High
- $30.00
- Low
- $16.00
- Targets Published, Last 12 Months
- 15
Recent Price Targets
The 5 most recent of at least 15 price targets published in the last 12 months.
| Date | Firm | Analyst | Target | Price When Posted |
|---|---|---|---|---|
| Oct 13, 2026 | Redburn Partners | Not named | $30.00 | $18.80 |
| Oct 12, 2026 | Jefferies | Michael Toomey | $22.00 | $19.71 |
| Oct 8, 2026 | Mizuho Securities | Not named | $28.00 | $19.11 |
| Oct 6, 2026 | Barclays | Not named | $22.00 | $19.64 |
| Sep 24, 2026 | Truist Financial | Not named | $29.00 | $20.54 |
Recent Upgrades & Downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 8, 2026 | Mizuho | maintain | Outperform | Outperform |
| Sep 3, 2026 | Morgan Stanley | maintain | Overweight | Overweight |
| Sep 2, 2026 | Mizuho | maintain | Outperform | Outperform |
| Sep 2, 2026 | B of A Securities | maintain | Buy | Buy |
| Sep 2, 2026 | Evercore ISI Group | maintain | Outperform | Outperform |
Quantitative Rating
MMED carries a model grade of B (overall score 3 of 5), computed from six valuation and financial measures (discounted cash flow, return on equity, return on assets, debt to equity, price to earnings and price to book), each scored 1 to 5. It is not an analyst rating.
How to Read MMED Analyst Coverage
Sell-side equity analysts publish three primary outputs: ratings (Strong Buy / Buy / Hold / Sell / Strong Sell, or firm-specific equivalents), price targets, and EPS / revenue estimate revisions. Rating consensus moves slowly relative to price; it reflects 12-month directional conviction rather than near-term momentum. Price targets are more responsive but typically drift behind realized price during sharp moves. The most actionable signal for options traders is a cluster of ratings actions across multiple firms within a short window, which compresses or expands implied volatility on a horizon of days to weeks and shifts the put-call skew toward the directional consensus. The recent-actions table above shows the five most recent firm-level changes; longer histories live behind aggregator sources.
For event-driven options sizing, pair the consensus rating and target distribution with the implied-volatility surface and dealer-positioning view. Aggressive target hikes from multiple firms tend to tighten put skew (downside protection becomes relatively cheaper); aggressive cuts widen put skew. The size of the IV response in the hours after a rating change is visible on the per-ticker volatility skew page and the gamma-exposure page, both of which show how dealer hedging propagates the analyst-driven flow into the listed options chain.
Learn how analyst ratings is reported and how to read the data →
Frequently asked MMED analyst ratings questions
- What is the MMED consensus price target?
- As of the latest aggregator update, MiniMed Group, Inc. (MMED) carries a consensus 12-month price target of $25.73. Target ranges run from a low of $16.00 to a high of $30.00. The target is the average of the price targets published by sell-side equity analysts covering the name.
- What is the analyst rating consensus on MMED?
- In the October 2026 monthly count, 15 analysts rated MMED, and the distribution tilts to the Buy side: 1 Strong Buy, 10 Buy, 3 Hold, 0 Sell and 1 Strong Sell. Rating consensus moves slowly relative to price; it reflects sell-side conviction over a 12-month horizon rather than near-term momentum.
- What recent ratings actions has MMED seen?
- The five most recent ratings actions on MMED appear on the page above. Sell-side rating changes are watched for two reasons: an upgrade or downgrade with a meaningful target revision moves the consensus and can trigger short-term positioning shifts, and the firm-level rating cluster (multiple firms moving in the same direction within a short window) is a clearer signal than any single action. Options markets often price the implied-vol response within minutes of the announcement.
- How do analyst targets affect MMED options pricing?
- Analyst target revisions tend to be priced in by the lit options market within minutes of publication, but persistent target drift over weeks does correlate with implied-volatility movement. Aggressive target hikes from multiple firms inside a single quarter tighten put skew (downside protection becomes cheaper relative to upside speculation); aggressive cuts widen put skew. The most actionable read is the implied-vol response in the hours after a target change, which is visible on the per-ticker volatility skew page.